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The glycoproteins of herpes simplex virus type 1
(HSV-1) are important targets for the immune
system in the control of HSV-1 infections. The
humoral and T cell responses to the glycoprotein
(g)Ht(His) :gL complex of HSV-1 were studied in seven
HSV-1-seropositive and three HSV-1-seronegative
healthy adults. In addition, responses to HSV-1 gDt
were determined. As antigens, purified soluble
recombinant forms of the gHt(His) :gL complex pro-
duced by insect cells and of gDt produced by yeast
cells were used. In contrast to seronegative donors,
sera of all seropositive donors contained gHt(His) :
gL-specific IgG. Using peripheral blood (PB) T cells,
gHt(His) :gL-specific proliferative T cell responses
were detected in all seropositive donors. Culture
supernatants of PB T cells stimulated with re-
combinant gHt(His) :gL contained high levels of inter-
feron-c and no detectable interleukin-4, indicating
their Th1 phenotype. These results show that
naturally acquired HSV-1 infection induces gH:gL-
specific humoral and T cell responses.
Herpes simplex viruses (HSV) are the causative agents of
localized skin infections of the oral, ocular, neural and genital
regions. In persons whose immune function is compromised,
severe and often disseminated HSV infections are observed. At
least 11 glycoproteins are encoded by HSV-1. Of these,
glycoproteins H and L (gH and gL) are present as a hetero-
dimer in the viral envelope and plasma membranes of HSV-1-
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infected cells (Hutchinson et al., 1992). The HSV-1 gH:gL
complex has an essential function in the fusion of the viral
envelope with the plasma membrane and in the cell-to-cell
spread of virions (Fuller & Lee, 1992 ; Forrester et al., 1992).
The formation of a hetero-dimer between gH and gL is
essential for correct folding and processing of gH (Roop et al.,
1993).
Of the HSV-1 glycoproteins, gD has been studied most
extensively with respect to immune responses and immuno-
logical properties. The role of HSV gH:gL as a possible target
of the immune system has been studied less extensively. It is
known that monoclonal antibodies (MAbs) to the gH:gL
complex can inhibit HSV-1 infections in vitro (Buckmaster et al.,
1984 ; Showalter et al., 1981). Passive administration of
neutralizing antibodies raised against the gH:gL complex
protects mice from zosteriform spread of HSV-1 infections
(Forrester et al., 1991 ; Simmons & Nash, 1985). However,
immunization studies with recombinant forms of gH and gL
(Ghiasi et al., 1992, 1994a, b) or recombinant vaccinia viruses
expressing gH, gL and gH:gL (Browne et al., 1993 ; Forrester
et al., 1991) induced only limited protection. Subsequently,
mice immunized with recombinant complexes consisting of
truncated gH and full-length gL produced by a mammalian cell
line were shown to be protected from a lethal HSV-1 challenge
(Peng et al., 1998).
This latter finding encouraged detailed investigations of
immune responses to the HSV-1 gH:gL complex in naturally
infected humans. In the present study, a soluble purified
recombinant form of the HSV-1 gH:gL complex, produced
and secreted by insect cells, was used to analyse the humoral
and peripheral blood (PB) T cell responses in seven HSV-1-
seropositive and threeHSV-1-seronegative healthy volunteers.
The seven HSV-seropositive donors had been naturally
infected by HSV-1 and most likely not by HSV-2, since none
of the sera reacted with recombinant gG2 fragments and gG2
peptides (Oda-Ikoma et al., 1998).
The recombinant complex, designated gH
t(His)
: gL, con-
sisted of full-length gL and truncated gH. The gH molecule
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Fig. 1. Recombinant antigens HSV-1 gHt(His) :gL and gDt. Purified
gHt(His) :gL (A, C, D) and gDt (A, B) were separated by 12–5%
SDS–PAGE. Proteins were visualized by silver staining (A) and by Western
blotting (B–D). For Western blotting, the proteins were transferred onto
PVDF membranes and subsequently incubated with gD-specific MAb A-16
(B), with gH-specific polyclonal antibody anti-gH1 (rabbit 83) and with
gL-specific polyclonal antibody W192S5. Membranes were subsequently
incubated with peroxidase-conjugated goat anti-mouse (B) or goat anti-
rabbit (C, D) antibodies. Antibody binding was visualized by a luminogenic
reaction. Marker proteins with molecular masses of 97, 70, 45 and
29 kDa are indicated.
was truncated before the transmembrane region at amino acid
791 and was tagged with the peptide RSHHHHHH at the C
terminus. High Five insect cells (Invitrogen) were infected with
recombinant baculoviruses containing the open reading frames
of both gH
t(His)
and gL under control of polyhedrin promoters.
After 72 h of infection, the culture medium (Insect Xpress,
BioWhittaker) was harvested. The gH
t(His)
: gL complex was
isolated in a one-step purification from the culture medium by
immobilized metal affinity chromatography (D. F. Westra,
unpublished). The purified gH
t(His)
: gL complex was obtained
with a high degree of purity, as analysed on SDS–poly-
acrylamide gels with subsequent silver staining (Fig. 1A). The
predicted molecular masses of gH
t(His)
, gL and gD
t
are 100,
30 and 47 kDa. Western blots with the appropriate antibodies
confirmed the identity of the bands seen on the silver-stained
gel (Fig. 1B–D). Size exclusion HPLC (data not shown) showed
that the gH
t(His)
: gL complex has a molecular mass of 125 kDa,
and confirmed that the complex is a hetero-dimer. The purified
gH
t(His)
: gL was recognized by MAb LP11, as assayed by
ELISA. Reactivity to LP11 is seen as indicative of correctly
folded gH:gL since this antibody recognizes gH only when
coexpressed with gL (Hutchinson et al., 1992).
In parallel, the humoral and PB T cell responses to soluble
recombinant HSV-1 gD were analysed. The gD
t
antigen,
truncated at residue 314, was produced in the methylotrophic
yeast Pichia pastoris. Recombinant gD
t
was purified from the
yeast medium by a two-step procedure. First, recombinant gD
t
was separated by anion exchange chromatography (Resource
Q column; Pharmacia) and, subsequently, gD
t
was further
purified by gel filtration (Superose 6 column; Pharmacia).
Recombinant HSV-1 gD
t
was seen as at least three diffuse
polypeptide bands (Fig. 1), most likely due to heterogeneous
glycosylation and proteolysis of gD
t
in yeast cell cultures, and
was recognized by gD-specific MAbs (data not shown).
The humoral responses to a crude HSV-1 lysate, and to
recombinants gH
t(His)
: gL and gD
t
were analysed by ELISA.
For the preparation of HSV antigen, Vero cells were infected
with HSV strain McIntyre (ATCC VR-539) at an m.o.i. of 10.
The infected cells were lysed by freeze–thawing followed by
heat-inactivation at 65 °C for 1 h. As a control, lysed mock-
infected Vero cells were used. The antigens were stored in
aliquots at fi80 °C. The presence of specific IgG in human sera
was analysed by ELISA. A lysate of HSV-1-infected Vero cells
and recombinant proteins gH
t(His)
: gL and gD
t
were coated
overnight in 50 mM sodium bicarbonate buffer pH 9–6. Serial
dilutions of the sera were incubated for 1 h. After washing,
horseradish peroxidase-conjugated rabbit anti-human IgG
antibodies (Dako) were added. The substrate O-phenylene-
diamine.HCl was used and colour development was measured.
The antibody levels were defined as the reciprocal of the serum
dilution which gave an A
%*&
of 0–5.
Seven HSV-1-seropositive individuals (donors 1–7) and
three HSV-1-seronegative individuals (donors 8–10) were
tested for IgG levels specific for HSV antigen and for
gH
t(His)
: gL complex and gD
t
(Table 1). Six out of seven HSV-
1-seropositive individuals had identical antibody levels to the
gH
t(His)
: gL complex. None of the HSV-1-seronegative donors
had significant IgG levels to the antigens tested. One
seropositive individual (donor 1) had a relatively low antibody
level to recombinant gH
t(His)
: gL. This response was, however,
still higher than those of the seronegative donors. The
antibody levels to gD
t
varied to a larger extent. Two donors
(donors 5 and 6) had both very high gD
t
-specific antibody and
very high HSV-specific antibody levels. In general, higher gD
t
-
specific antibody levels correlated with higher HSV-specific
antibody levels. This correlation was not seen for the antibody
levels specific for the gH
t(His)
: gL complex. In three out of
seven HSV-seropositive individuals, the gH
t(His)
: gL antibody
levels were higher than the antibody levels for gD
t
(Table 1).
The data suggest that the HSV gH:gL complex is an important
antigen to which humoral immune responses are elicited upon
natural HSV infection.
Peng et al. (1998) showed that sera from mice and rabbits
which were immunized with correctly folded recombinant
HSV-1 gH
t
: gL complex had antibodies which neutralized
HSV-1 in vitro. However, the possible protective role of these
neutralizing antibodies in vivo was not addressed in this study.
Passive administration of an HSV-1 gH:gL-specific MAb has
been shown to protect mice from zosteriform HSV-1 infection
(Simmons & Nash, 1985). To date, homologues of the gH:gL
complex have been found in all herpesviruses investigated. In
human donors naturally infected with the herpesvirus human
cytomegalovirus (CMV), CMV gH has been identified as a
major target antigen of the CMV-specific neutralizing anti-
bodies (Urban et al., 1996). Consequently, HSV-1 gH:gL-
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Table 1. Serum IgG antibody levels and PB T cell responses to crude HSV-1/Vero lysate and recombinant proteins
HSV-1 gHt(His) :gL and gDt
[3H]Thymidine incorporation (SI)
Antibody level*
Vero/mock
Vero/HSV-1
Medium
gHt(His) :gL gDt
Donor HSV-1 gHt(His) :gL gDt c.p.m. c.p.m. SI c.p.m. c.p.m. SI c.p.m. SI
1 3000 300 1600 775 41586 54 547 5618 10 33037 60
2 5000 2800 1600 1625 48689 30 260 5599 21 17464 67
3 12000 2800 6000 603 37661 62 370 7690 21 40820 110
4 5500 2600 1600 1170 102821 88 656 17707 27 20672 32
5 80000 2800 19000 1507 45569 30 429 6365 15 5111 23
6 50000 2600 25000 1242 61623 50 379 3544 9 30663 81
7 3500 3200 1600 830 67613 81 721 13613 19 28088 39
8 ! 100 ! 100 ! 100 1721 642 ! 1 1 226 600 ! 1 2211 2
9 ! 100 ! 100 ! 100 240 829 4 216 2430 11 1225 6
10 ! 100 ! 100 150 540 296 ! 1 567 617 1 1479 3
* Antibody levels were determined by ELISA. Purified recombinants gH
t(His)
: gL and gD
t
and lysates of HSV-1-infected Vero cells were used as
antigens. The antibody levels were defined as the reciprocal of the serum dilution which gave an A
%*&
of 0–5.
 Proliferative responses of 10& PBMC against lysates of mock- (Vero}mock) and HSV-1-infected Vero cells (Vero}HSV-1), purified recombinants
gH
t(His)
: gL (20 lg}ml), gD
t
(20 lg}ml) and medium control (medium) were measured in a 6 day lymphocyte proliferation assay by [$H]thymidine
incorporation for the final 16 h. Data presented are means of triplicate cultures in counts per minute (c.p.m.) and the stimulation indices (SI) are
given.
Table 2. Concentrations of gamma interferon (IFN-c) and interleukin 4 (IL-4) in culture
supernatants of antigen-stimulated PBMC
Cytokine concentrations (pg}ml) were measured by ELISA in the culture supernatants of PBMC cultures after
a 6 day stimulation with a crude lysate of HSV-1-infected Vero cells (Vero}HSV-1), and 20 lg}ml of purified
recombinants HSV-1gH
t(his)
: gL and gD
t
, respectively. The detection limits of the ELISA for IFN-c and IL-4
were 5 pg}ml.
IFN-c IL-4
Donor Vero/HSV-1 Medium gHt(His) :gL gDt Vero/HSV-1 Medium gHt(His) :gL gDt
1 4047 11 3122 3321 ! 5 ! 5 ! 5 ! 5
2 4545 12 2875 1249 ! 5 ! 5 ! 5 ! 5
3 2556 11 1033 2329 ! 5 ! 5 ! 5 ! 5
4 3542 11 2306 1102 ! 5 ! 5 ! 5 ! 5
5 2202 12 1053 743 ! 5 ! 5 ! 5 ! 5
6 2669 11 830 3252 ! 5 ! 5 ! 5 ! 5
7 3789 13 2954 3377 ! 5 ! 5 ! 5 ! 5
8 13 12 100 111 ! 5 ! 5 ! 5 ! 5
9 322 12 672 161 ! 5 ! 5 ! 5 ! 5
10 34 11 20 72 ! 5 ! 5 ! 5 ! 5
specific antibodies may have an important role in controlling
HSV-1 infection.
Proliferative responses of freshly isolated peripheral blood
mononuclear cells (PBMC) to lysates of HSV-1-infected Vero
cells and to recombinants gH
t(His)
: gL and gD
t
were examined
in a lymphocyte proliferation assay. PBMC were isolated by
density centrifugation of heparinized PB on a Ficoll gradient
(Lymphoprep ; Nycomed) and were cultured in RPMI 1640
supplemented with 10% heat-inactivated human serum. 10&
PBMC per well were incubated with recombinant gD
t
(1, 5, 10
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and 20 lg}ml), recombinant gH
t(His)
: gL (1, 5, 10 and
20 lg}ml) and lysates of mock-infected and HSV-1-infected
Vero cells. T cell proliferation was measured as $[H]thymidine
incorporation over the last 16 h of a 6 day culture period. The
stimulation index (SI) for HSV was calculated as the quotient of
c.p.m. from cultures stimulated with a lysate of HSV-1-infected
Vero cells to c.p.m. from cultures stimulated with a lysate of
uninfected Vero cells. The SI for gH
t(His)
: gL and gD
t
was
calculated as the quotient of c.p.m. from cultures stimulated
with the purified glycoproteins to c.p.m. of unstimulated
cultures.
PBMC of seven seropositive and three seronegative
healthy adult donors were tested on two or more occasions
with the antigens. Data from a representative experiment are
shown in Table 1. The PB T cells of all HSV-seropositive
donors (donors 1–7) responded to lysates of HSV-1-infected
Vero cells, recombinant HSV-1 gH
t(His)
: gL and gD
t
. Among
the three seronegative donors, two donors did not respond to
the HSV antigens and donor 9 demonstrated profound PB T
cell responses to the two recombinant HSV-1 glycoproteins
with only a marginal response to Vero}HSV-1 lysate. The data
indicate that following a natural HSV-1 infection, HSV-1 gD
but also gH:gL-specific T cell immunity is elicited. Given the
nature of the antigen, e.g. exogenous antigen, the antigen-
specific T cell responses measured in vitro were most likely
orchestrated by CD4+ T cells.
T helper cells can be divided into subsets, Th1 and Th2,
based on their production of distinct patterns of cytokines.
Typical Th1 and Th2 cytokines are interferon (IFN)-c and
interleukin (IL)-4, respectively (Biron, 1994). To determine the
Th subset of the antigen-specific PB T cells, the secretion of
IFN-c and IL-4 by antigen-stimulated PB T cells of the HSV-
seronegative and -seropositive donors was measured (Table 2).
After antigenic stimulation for 6 days, cell-free culture
supernatants were assayed for IFN-c and IL-4 with commercial
ELISA kits as described by Verjans et al. (1998b). PB T cell
cultures from donors 1–7 stimulated with HSV-1 lysate, gD
t
,
and gH
t(His)
: gL secreted large amounts of IFN-c and no
detectable IL-4 (Table 2). Interestingly, PB T cells from donor
9 also secreted significant amounts of IFN-c upon stimulation
with HSV-1 antigen and recombinant gH
t(His)
: gL, and, to
a lesser extent, gD
t
(Table 2). These results indicated,
as described previously, that the HSV-1-specific PB T cell
response is Th1-like (Ghiasi et al., 1992 ; Biron, 1994 ; Carmack
et al., 1996 ; Cher & Mosmann, 1987 ; Hendricks et al., 1992).
The HSV-1 glycoproteins gB, gC and gD have been
identified as major targets for cytolytic HSV-1-specific CD4+ T
cells (Mikloska & Cunningham, 1998). In that study, HLA-DR-
expressing human epidermal keratinocytes, infected with
recombinant vaccinia virus expressing gB, gC, gD or gH, were
used as target cells. The highest cytotoxicity was measured for
gD, followed by gB or gC, and then by gH. Beninga et al.
(1995) analysed the T cell responses to CMV; three out of five
CMV-specific T cell lines, mainly consisting of CD4+CD8− T
cells, responded to CMV gH (Beninga et al., 1996). Our study
indicates that naturally acquired HSV-1 infection elicits a
gH:gL-specific Th1 response. All HSV-seropositive donors
responded to gH
t(His)
: gL in the proliferation assay. Two of
the three seronegative donors were negative. The result of the
proliferation studies with the PB T cells of HSV-seronegative
donor 9 is puzzling. Despite the PB T cell response against gD
t
and gH
t(His)
: gL complex, the donor was still HSV-sero-
negative 1 year after the proliferation assays. The proliferative
response to gH
t(His)
: gL could have been caused by PB T cells
which recognize peptides of the gH:gL complex of other
human herpesviruses. Parts of the gH:gL complex are
conserved among herpesviruses. However, the gD
t
-specific
proliferative response cannot be explained by such a homology
because, except for HSV-2, there are no homologues of
gD in other human herpesviruses. We cannot exclude the
possibility that, despite the absence of contaminating proteins
present on the silver-stained SDS-gel, the relatively low PB T
responses of donor 9 to gH
t(His)
: gL and gD
t
might be directed
against contaminating proteins present in very low amounts in
the antigen preparations.
The role of T cell immunity in controlling systemic and
local HSV-1 infections has been studied extensively. HSV-
specific CD4+ and CD8+ cells with cytotoxic and}or pro-
liferating activities are present in high frequencies in PB cells
and herpetic lesions (Verjans et al., 1998a, b ; Schmid, 1988 ;
Posavad et al., 1996 ; Carmack et al., 1996 ; Koelle et al., 1994).
The role of CD8+ T cells may be limited because HSV-infected
cells have a reduced surface expression of MHC class I
molecules (Hill et al., 1995 ; York et al., 1994). Nonetheless,
CD8+ lymphocytes may have an important function in later
stages of herpetic lesions. This is because IFN-c secreted by
stimulated CD4+ Th1 cells upregulates MHC class I expression
on HSV-infected cells (Posavad et al., 1998). Alternatively,
some cells may be less susceptible to the HSV-induced
downregulation of MHC class I (Posavad et al., 1996).
The observation that a natural HSV-1 infection elicits both
a T cell (Th1-like) and humoral response to the HSV-1 gH:gL-
complex may be of importance for the development of a
subunit vaccine. Taking into account the finding that immuni-
zation with soluble recombinant HSV-1 gH:gL protects mice
from a lethal HSV-1 challenge (Peng et al., 1998), the soluble
gH:gL complex may be an important candidate as a com-
ponent of an effective subunit vaccine for the prevention
and}or control of HSV infections.
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